Cargando…

Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression

Bone marrow suppression is a common complication of chemotherapy. In order to observe the effects of Shuanghe Jiyu decoction on peripheral white blood cells (WBC), hemoglobin (Hb), and platelet (PLT) in patients with bone marrow suppression, a total of 126 patients with bone marrow suppression were...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Dapeng, Zhao, Jing, Ren, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470345/
https://www.ncbi.nlm.nih.gov/pubmed/36128171
http://dx.doi.org/10.1155/2022/9333718
_version_ 1784788821418704896
author Yao, Dapeng
Zhao, Jing
Ren, Yanling
author_facet Yao, Dapeng
Zhao, Jing
Ren, Yanling
author_sort Yao, Dapeng
collection PubMed
description Bone marrow suppression is a common complication of chemotherapy. In order to observe the effects of Shuanghe Jiyu decoction on peripheral white blood cells (WBC), hemoglobin (Hb), and platelet (PLT) in patients with bone marrow suppression, a total of 126 patients with bone marrow suppression were given at least three consecutive cycles of chemotherapy. The results show that among 126 patients with bone marrow suppression, 16 achieved marked efficacy and 100 achieved moderate efficacy. The overall effective rate is 92.06%. Moreover, the symptoms of bone marrow suppression are mitigated. No adverse events are reported during the treatment.
format Online
Article
Text
id pubmed-9470345
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94703452022-09-19 Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression Yao, Dapeng Zhao, Jing Ren, Yanling Contrast Media Mol Imaging Research Article Bone marrow suppression is a common complication of chemotherapy. In order to observe the effects of Shuanghe Jiyu decoction on peripheral white blood cells (WBC), hemoglobin (Hb), and platelet (PLT) in patients with bone marrow suppression, a total of 126 patients with bone marrow suppression were given at least three consecutive cycles of chemotherapy. The results show that among 126 patients with bone marrow suppression, 16 achieved marked efficacy and 100 achieved moderate efficacy. The overall effective rate is 92.06%. Moreover, the symptoms of bone marrow suppression are mitigated. No adverse events are reported during the treatment. Hindawi 2022-09-06 /pmc/articles/PMC9470345/ /pubmed/36128171 http://dx.doi.org/10.1155/2022/9333718 Text en Copyright © 2022 Dapeng Yao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yao, Dapeng
Zhao, Jing
Ren, Yanling
Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression
title Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression
title_full Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression
title_fullStr Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression
title_full_unstemmed Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression
title_short Efficacy of Shuanghe Jiyu Decoction in 126 Patients with Bone Marrow Suppression
title_sort efficacy of shuanghe jiyu decoction in 126 patients with bone marrow suppression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470345/
https://www.ncbi.nlm.nih.gov/pubmed/36128171
http://dx.doi.org/10.1155/2022/9333718
work_keys_str_mv AT yaodapeng efficacyofshuanghejiyudecoctionin126patientswithbonemarrowsuppression
AT zhaojing efficacyofshuanghejiyudecoctionin126patientswithbonemarrowsuppression
AT renyanling efficacyofshuanghejiyudecoctionin126patientswithbonemarrowsuppression